Sherbrooke Park Advisers »

Nurix Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $100k 11k 9.24

More positions owned by Sherbrooke Park Advisers

Airbnb Com Cl A (ABNB)
Duolingo Cl A Com (DUOL)
Atlassian Corporation Cl A (TEAM)
Bright Horizons Fam Sol In D (BFAM)
Iridium Communications (IRDM)
Metropcs Communications (TMUS)
Ringcentral Cl A (RNG)
Intuitive Surgical Com New (ISRG)
Darden Restaurants (DRI)
Hasbro (HAS)
Boston Scientific Corporation (BSX)
Gilead Sciences (GILD)
Amer Sports Com Shs (AS)
At&t (T)
Draftkings Com Cl A (DKNG)

View all positions for Sherbrooke Park Advisers

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Baker Bros. Advisors
Commodore Capital
Redmile Group
Vestal Point Capital
Point72 Asset Management
State Street Corporation
Soleus Capital Management
Kynam Capital Management
Morgan Stanley
Pictet Asset Management Holding SA
Geode Capital Management

View all funds holding Nurix Therapeutics